Product Information

ALISKIREN 150 MG TABLET is a generic product labeled by Prasco Laboratories, priced at $4.0474 per EA under NDC 66993014130. Its NADAC has been published 379 times since May 22, 2019.

FDA first approved this application on Mar 5, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ALISKIREN 150 MG TABLET

aliskiren hemifumarate
$4.0474per EA

Strength

150 mg/1

NDC

66993014130

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

ALISKIREN HEMIFUMARATE

Approval Type

Authorized Generic (NDA)

FDA Application

NDA021985

FDA Approved

3/5/2007

TE Code

AB

On Market Since

3/4/2019

Pharmacological Classes

Renin Inhibitor
Renin Inhibitors

Price Statistics

The NADAC for ALISKIREN 150 MG TABLET has been published 379 times since May 22, 2019, and over the history we have for it it has declined 31.6%. The table below summarizes its recorded NADAC range and movement.

Current price$4.0474 per EA
All-time high$6.0323 (Jul 15, 2020)
All-time low$3.5677 (Jun 19, 2024)
52-week high$4.3921
52-week low$4.0009
Median price$5.0066
Average price$5.0325
Largest weekly change-26.2% (Mar 22, 2023)
Weeks tracked379
Tracking sinceMay 22, 2019

Price History

1W

-0.7%

1M

-0.7%

3M

-4.1%

6M

-7.5%

1Y

-3.6%

3Y

-17.5%

5Y

-31.9%

All

-31.6%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of ALISKIREN 150 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ALISKIREN 150 MG TABLET, manufactured by Prasco Laboratories, is $4.0474 per EA (NDC 66993014130), effective Aug 19, 2026.

How has the price of ALISKIREN 150 MG TABLET changed over time?

Over the history we have for it, the NADAC for ALISKIREN 150 MG TABLET has declined 31.6%. It has been tracked across 379 weekly CMS publications since May 22, 2019.

What are the highest and lowest recorded NADAC prices for ALISKIREN 150 MG TABLET?

Since May 22, 2019, the NADAC for ALISKIREN 150 MG TABLET has ranged from a low of $3.5677 (Jun 19, 2024) to a high of $6.0323 (Jul 15, 2020), with a median of $5.0066 per EA.

Are there cheaper alternatives to ALISKIREN 150 MG TABLET?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as ALISKIREN 150 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures ALISKIREN 150 MG TABLET?

ALISKIREN 150 MG TABLET (NDC 66993014130) is labeled by Prasco Laboratories, and CMS classifies it as a generic product.